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Computational design of syntheses leading to compound 
libraries or isotopically labelled targets
Whereas human chemists are trained in and accustomed to 
designing pathways leading to individual targets, computers can 
multiplex this task and design “global” synthetic plans leading to 
entire target libraries and/or multiple isotopomers. This study 
describes how network-search routines within the Chematica 
program can be adapted to such multi-target design while operating 
on one common search graph. Examples of library-wide synthetic 
design applied to targets of current medicinal interest illustrate 
how the machine skilfully construct plans beneﬁ ting from the 
use of common intermediates and thus off ering signiﬁ cant 
reduction of cost.
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compound libraries or isotopically labelled targets†
Karol Molga, ‡a Piotr Dittwald‡a and Bartosz A. Grzybowski *ab
Although computer programs for retrosynthetic planning have shown improved and in some cases quite
satisfactory performance in designing routes leading to speciﬁc, individual targets, no algorithms capable
of planning syntheses of entire target libraries – important in modern drug discovery – have yet been
reported. This study describes how network-search routines underlying existing retrosynthetic programs
can be adapted and extended to multi-target design operating on one common search graph,
beneﬁtting from the use of common intermediates and reducing the overall synthetic cost.
Implementation in the Chematica platform illustrates the usefulness of such algorithms in the syntheses
of either (i) all members of a user-deﬁned library, or (ii) the most synthetically accessible members of this
library. In the latter case, algorithms are also readily adapted to the identiﬁcation of the most facile
syntheses of isotopically labelled targets. These examples are industrially relevant in the context of hit-
to-lead optimization and syntheses of isotopomers of various bioactive molecules.Introduction
Capitalizing on the advances in articial intelligence1–4 and
constantly increasing computing power, recent years have
brought revived interest and signicant progress in the
decades-old challenge of teaching computers the design of
multistep organic syntheses.5–9 Various platforms, diﬀering in
the underlying details of search algorithms and reaction-rule
formats, have been developed10–21 and one of these platforms,
our own Chematica,17–21 has been validated experimentally via
successful execution of multiple routes leading to diverse, high-
value, medicinally relevant small molecules18 and, more
recently, natural products.19 To date, a main eﬀort in this
emerging area of chemical research has been on algorithms
designing syntheses of one specied target at a time. In several
practically/industrially important situations, however, it is
desirable to simultaneously design routes to multiple targets.
For instance, a medicinal chemist might wish to optimize an
existing scaﬀold and place various substituents in positions of
interest (e.g., R1, R2, and R3 in Fig. 1a). Such hit-to-lead or lead
optimizations22,23 encompass libraries of multiple synthetic
targets, raising some pertinent questions: (1) which of the
targets are most readily synthesizable? or (2) how to synthesize
all of the targets while making use of some possible commondemy of Sciences, ul. Kasprzaka 44/52,
wski@gmail.com
d Department of Chemistry, UNIST, 50,
9-798, South Korea
tion (ESI) available. See DOI:
hemistry 2019intermediates? Another situation of interest is when one wishes
to design syntheses of isotopically labelled compounds that
diﬀer from the parent, non-labelled compound by a certain
increment of molecular mass – this ability is important to
determine drugs' pharmacokinetics,24,25 to study environmental
fates of pesticides,26,27 to ascertain food safety,28–30 or to quantify
food avourings,31–33 in many cases using the so-called isotope
dilution mass spectroscopy (IDMS) techniques and assays.34
Because isotope labels can be placed in various positions and in
various congurations within the molecule leading to iso-
topomers (Fig. 1b), they, again, constitute a small library of
potential targets. In this case, question (1) – which of the
labelled compounds oﬀering a desired mass increase are most
readily synthesizable – appears most relevant. Currently, there
are no retrosynthetic algorithms with which one could address
such questions for arbitrary targets. The closest analogue is our
earlier work on the so-called Network of Organic Chemistry35–37
(NOC), in which we usedMonte-Carlo searches to select (but not
design) optimal syntheses leading to multiple targets of
interest.37 Unfortunately, NOC is a static network comprising
only published literature precedents and so its analyses are
limited to already known targets and existing synthetic routes.
In addition, Monte Carlo searches are computationally very
intensive and typical execution times for the NOC are in days.
Here, we describe signicantly more eﬃcient and general
algorithms for de novo retrosynthetic planning (i.e., planning
based on general reaction rules, not existing literature prece-
dents) producing routes to small libraries of arbitrary – that is,
both known and unknown – targets, including labelled ones. In
our algorithms, retrosynthetic searches for individual targets
share the same search graph and can benet from commonChem. Sci., 2019, 10, 9219–9232 | 9219
Fig. 1 Examples of multiple-target libraries. (a) Library of chlorcycli-
zine derivatives screened for the treatment of hepatitis C virus in ref.
38. (b) Isotopomers of ibuprofen. Top row has two examples of M + 1
isotopomers possible with 13C (left) and 2H (right) labelling. Bottom
row has two examples of M+2 isotopomers available via 13C (left) and
2H (right) labelling. Green numerals within the molecules give the total
numbers of unique (note: some hydrogens and carbons are equiva-
lent) labelled compounds for each case. For the M+2 labelling of this
structurally simple target, there are already 49 13C and 28 2H labelling
combinations. The number of isotopomers corresponds to sets
without 2H labelling of the COOH group which is extremely easily
exchangeable. (c) To specify multiple targets of retrosynthetic anal-
yses, it is often convenient to use the so-called Markush structures.
Here, a set of molecules is represented as a SMILES string (black) with
numbered dummy atoms ([*:1],[*:2]) and dictionary of substituents
marked in red and green for positions #1 and #2, respectively. Position
[*:1] can correspond to either an aromatic carbon or nitrogen (to yield,
respectively, biphenyl and 2-phenylpyridine series), whereas position
[*:2] admits either a nitrile, CN, or F, or Cl atoms. In all, the small library
thus deﬁned will have six members shown in panel (d).
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View Article Onlineintermediates and synthetic strategies. In several cases, these
searches utilize a cyclically inspected list of priority-queue-
based data structures rather than a single priority-queue; this
construction ensures that the overall, multi-target search is not
dominated by a sub-search for any individual target. Examples
of specic and in all cases viable syntheses we describe evidence
that multi-target planning routines make eﬃcient use of
common intermediates, reduce the search space signicantly
(compared to individual, target-by-target searches), and yield
complete library-wide plans within minutes. Overall, the
methods we describe extend applicability of computational
retrosynthetic planning to problems that are ubiquitous and
important in pharmaceutical and agrochemical industries,
oﬀering savings in terms of planning time and the overall cost
of synthesis of compound libraries, as well as minimization of
waste (through the maximally eﬃcient use of common9220 | Chem. Sci., 2019, 10, 9219–9232intermediates and “root” reactions in the global, library-wide
reaction plans). In a broader context, the multi-target design
harnesses the computer's ability to store, analyze, and optimize
large, interconnected networks of synthetic plans, whichmay be
diﬃcult for human chemists accustomed to planning synthetic
solutions to specic targets, one target at a time.Computational methods
Modern retrosynthetic planners (e.g., MIT's ASKCOS,15 Waller's
MCTS,14 or our Chematica17–21) diﬀer in the origin of the
underlying reaction rules (machine extracted vs. expert coded)
and details of the search routines, but they all rely on the iter-
ative expansion of parent/retron nodes into progeny/synthon
nodes and on navigating (with the help of functions scoring
individual reaction moves) the thus created bipartite graphs of
synthetic options until simple and commercially available
substrates are found. This procedure yields pathways that lead
to a given target of interest and in which all chemical nodes are
“synthesizable” (i.e., they are targets of at least one synthetic
pathway tracing back to commercially available substrates) and
the reaction nodes are “viable” (i.e., all their substrates are
synthesizable). The problem we focus on in the current study is
how to extend such generic routines to enable simultaneous
synthesis of multiple targets (“a library”).Algorithm seeking the syntheses of all targets
We begin by discussing the simplest problem of identifying
syntheses of all members of a library. The algorithm (Fig. 2 and
pseudocode in the ESI, Section S1†) initializes by performing
a dummy “multicomponent” reaction, rdummy, such that the root
node (i.e., the library) is “made” in one step from all molecules in
the library, {mi}, i¼ 1,.,N, serving as its substrates. Chemically,
this is a purely ctitious operation but algorithmically, such
search-graph construction is important as it serves as an “AND”
condition ensuring that any viable syntheses (cf. denition of
viability above and in ref. 21) of the root node will also have to
make all substrates for the ultimate rdummy reaction – in other
words, the search algorithmwill not stop until viable syntheses of
all mi molecules in the library are identied. Of course, this
dummy reaction is not supposed to skew the real searches formis
in any way, and its execution cost is assigned as zero. Starting
from the mi nodes, the search graph is iteratively expanded as
described before,18 with the already-evaluated sets of synthons
stored in a single priority-queue-based data structure (PQ), and
with further synthetic navigation guided by desired scoring
functions (in Chematica, the synthetic moves are guided by
summing the costs of the already-performed reactions and the
complexity of synthons created by each reaction;17,18 in programs
like ASKCOS or Waller's MCTS, the navigation is based on the
scores provided by neural networks trained on large numbers of
reaction precedents14,15). The stop points for the search are known
and/or commercially available molecules with prices of the latter
typically taken from commercial catalogues.
As the search is allowed to progress, multiple viable
syntheses are typically found, forming a solution graph fromThis journal is © The Royal Society of Chemistry 2019
Fig. 2 Schematic description of the algorithm seeking the syntheses of all targets. (a) The user speciﬁes the target set (here, TS ¼ library of four
targets), deﬁning the root node (yellow circle) of the search graph to be explored (shaded parts represent regions of the graph not yet expanded).
(b) The search graph is extended by adding four additional substance nodes (violet circles labelled m1, m2, m3, m4), linked with the root node via
the same dummy reaction (orange diamond). The search algorithm utilizes a single priority-queue-based data structure, PQ, to navigate the
graph expansion according to scores assigned to speciﬁc synthetic “options” encountered during the search. For this illustrative example, the
algorithm ﬁrst expands node m2, having a better score than nodes m1, m3, and m4. (c). Three explored reactions (grey diamond-shaped reaction
nodes) lead to possibly overlapping substrate sets – i.e., nodes labelled {1, 2}, {2, 3}, and {4, 5}, respectively. Violet circular nodes denote
molecules that are unknown in literature and not commercially available; red circular nodes refer to terminal, commercially available, chemicals.
Here, one synthesis, i.e., 4, 5/m2, gives viable synthesis plan for target m2 (green halo denoting that m2 is synthesizable). The search proceeds
to (i) ﬁnd syntheses for the remaining targets m1, m3, m4, and (ii) ﬁnd alternative synthesis plans for target m2. (d) Search continues expanding
nodem4, giving reactions with substrates {6, 7}, and {8}, then expanding nodem3 (e) resulting in reactions' substrate sets {5}, {6}, {9} (nodes 5 and
9 were already visited in previous expansions; moreover, as node 5 is terminal, path 5/ m3 is a viable synthesis for m3). (f) Furthermore, the
region of the search graph related to the synthesis of m1 is visited by exploring node 10, and nodes 11 and 12. (g) The path 12/ 10/ m1 is
a viable synthesis, so the target m1 is now also synthesizable. (h) Then, node 6 is expanded, giving terminal node 13. Of note, 6 is a common
intermediate for syntheses of targets m3, and m4, and these two targets have new viable syntheses (13/ 6/m3, and 13/ 6, 7/m4). Target
m4 is now synthesizable, and viable synthesis plans can by retrieved for all targets from initial target set (operation performed by selection
algorithm, seemain text). (i) The search continues to ﬁndmore synthesis options, here exploring node 8 to give reactionwith substrates 13 and 14
(resulting in alternative synthesis for target m4: 13, 14/ 8/ m4).
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View Article Onlinewhich most economical plans can be selected (by iteratively
propagating the yield-scaled costs from substrates to products
and thereby assigning a realistic, monetary cost to each plan). In
addition to the selection procedures detailed in our recent
publication,21 a unique feature of library-wide design is that we
wish to promote convergent synthetic plans that make use not
only of common intermediates but also of the smallest number
of diﬀerent synthetic methodologies – to this end, a penalty is
added to any new reaction type encountered in the solution
graph. Chemically, such penalization ensures that it is more
economical to perform the same reaction on a, say, 2 mol scale,
rather than two diﬀerent types of reactions – requiring separate
set-ups and likely diﬀerent reagents – each on a scale of 1 mol.
We observe that if the searches for each library member were
performed separately, selection would be made from each
individual solution graph and no synergies in terms of commonThis journal is © The Royal Society of Chemistry 2019intermediates or reaction types could, in general, be expected.
Also, in terms of computational eﬃciency, the search on
a common graph is signicantly more compact than the sum of
individual searches – as quantied for specic examples we
discuss later in the text (cf. Fig. 4, 5 and Table S1†), the number
of graph nodes explored before nding the rst viable solution
is about an order of magnitude smaller for the library-oriented,
global search than for separate searches; each ran for a diﬀerent
library member.Algorithm seeking the easiest syntheses of some targets
In some cases, not all members of a library are equally diﬃcult
to synthesize, and one could wish to perform wet-lab execution
of only those that are most readily synthesizable. Algorithmi-
cally, this task is a bit more nuanced than nding syntheses ofChem. Sci., 2019, 10, 9219–9232 | 9221
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View Article Onlineall targets in the library. To illustrate, let us assume that
a search for the synthesis of target m1 does not nd any solu-
tions aer a certain time – if this target is extremely hard to
synthesize and yet the algorithm continues to nd its synthesis,
it might be stuck in this one search while other targets could
yield solutions in shorter times. On the other hand, we do not
know a priori if these other targets are any simpler. To overcome
such problems, we implemented a multi-priority-queue algo-
rithm that allows syntheses of diﬀerent targets to be explored toFig. 3 Schematic description of the algorithm seeking the syntheses of
circle) corresponds to the target set (here, TS¼ library of four targets). (b) T
m1, m2, m3, m4), each linked with the root node via a separate dummy re
structures, PQ1, PQ2, PQ3, and PQ4, each corresponding to a separate ta
PQ1, then PQ2, PQ3, PQ4, PQ1, etc.). PL is responsible for balanced explor
halo marks this data structure as currently inspected), m1 is expanded, ide
nodes refer to unknown chemicals). (d) Then, as PQ2 is inspected, node m
sets {3, 4} and {5, 6}, respectively; red circular nodes represent terminal, co
halo), with a viable synthesis 3, 4/ m2 already satisfying the condition
search continues to ﬁnd alternative pathways. (e) According to PQ3, n
identiﬁed (6 already appeared while searching for syntheses of m2). (f) T
(now, a common intermediate in the synthesis plans leading to m3 and
nodes 1 and 2 (previously visited while searching for the synthetic scena
search continues, PQ2 is inspected again, discovering viable synthesis (fro
i.e., node 6. Consequently, m3 becomes synthesizable, and pathways 14
initial task. (i) Subsequently, the algorithm inspects PQ3, node 8 is explore
becomes synthesizable (newly discovered pathways are 15/ 8/ m3,
identiﬁed during the search are retrieved and ranked according to a sep
9222 | Chem. Sci., 2019, 10, 9219–9232comparable levels, while sharing information about common
intermediates and chemistries, and returning the best-scoring
pathways taking into account the aggregated results for all
targets considered. Specically, the algorithm (Fig. 3 and
pseudocode in the ESI, Section S2†) initializes not from a single
“dummy” reaction (cf. previous section) but from N such reac-
tions, each linking the terminal root/library node with one
specic member of the library {m1, ., mN}. This construction
serves as an “OR” condition and ensures that any viablesome, most-synthetically-accessible targets. (a) The root node (yellow
he graph is extended by creating four substrates (violet circles denoted
action (orange diamonds). Additionally, four priority-queue-based data
rget node, compose a priority-list, PL, inspected in circular order (ﬁrst
ation of syntheses leading to each target. (c) According to PQ1 (orange
ntifying a reaction (grey diamond) from substrates 1 and 2 (violet circle
2 is expanded and two reactions are added to the graph (with substrate
mmercially available chemicals). Targetm2 is now synthesizable (green
of ﬁnding a synthesis of at least one member of the target library. The
ode m3 is expanded, and reactions with substrates {6, 7} and {8} are
hen, as PQ4 is inspected, m4 is expanded, giving reaction from node 8
m4) and node 9. (g) Inspection of the priority lists now returns to PQ1,
rio of m1) are explored, giving new nodes 10, 11, 12, and 13. (h) As the
m terminal node 14) leading to a common intermediate of m2 and m3,
/ 5, 6/ m2 and 14/ 6, 7/m3 become plausible solutions of the
d by two reactions, each starting at terminal nodes (15 and 16), and m4
16/ 8/ m3, 15/ 8/ m4, and 16/ 8/ m4). All viable pathways
arate selection algorithm (see ref. 21).
This journal is © The Royal Society of Chemistry 2019
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View Article Onlinepathway to the root node will also synthesize one of the mi,
molecules. Moreover, to ensure that all targets m1, ., mN are
being analyzed to comparable degrees, we use the priority-list,
PL, rather than a single, global priority queue-based data
structure, PQ. This PL (1) has length N; (2) its i-th element, PL[i],
is a PQ initialized with a single-element set {m}i; (3) synthon sets
from the PL are retrieved in circular order, i.e., PL[1], PL[2],.,
PL[N], PL[1], PL[2], .; and (4) when a synthon set S is taken
from PL[i], and is further expanded into progeny synthon sets,
these progenies are also inserted to PL[i]. In other words,
although the search uses one common graph and still benets
from the use of common intermediates/chemistries, each target
has its separate PQ which stores the synthetic options for this
target and, importantly, is inspected cyclically. As solutions are
being found, a selection procedure21 is applied to the entire
solution graph (encompassing pathways leading to diﬀerent
targets), to select the best individual syntheses (shortest, most
economical, and chemically diverse routes). Unlike the “nd
all” modality we described earlier, for which the outcome was
a global graph encompassing syntheses of all library members,
the end result of the “nd best” analysis is a list of individual
synthetic solutions ranked in descending order of the ease of
synthesis.Algorithm seeking the most feasible syntheses of multiple
isotopomers
For this sub-problem, our aim is to nd the most readily syn-
thesizable isotopomer that increases the molecular mass by
a user-specied value. The library here is a set of possible iso-
topomers and the search problem itself is identical to the one
described in the previous section with the searches terminating
in isotopically labelled (and possibly some non-labelled),
commercially available starting materials. The diﬀerence lies
in the way in which the target library is generated – in partic-
ular, we would like to automate the generation of all iso-
topomers oﬀering the desired mass increase. The procedure to
do so begins with specifying the non-labelled target molecule,
a desired mass shi, S (positive or negative), and the availa-
ble_iso list of isotopes one wishes to use. The list should contain
isotopes with only positive or only negative mass shis, corre-
sponding to the sign of S (e.g., if S > 0, 13C but not 11C should be
used). This condition precludes generation of several nonsen-
sical isotopomers in which, for example, a mass shi of +1
could be obtained by introducing two 13Cs and one 11C. Addi-
tionally, one may wish to specify which atoms should not be
labelled (e.g., 2H labelled carboxylic acids, amines, or alcohols
are labile, whereas 13C labelling should be avoided in meta-
bolically unstable fragments such as esters or N-methylamines).
With such assumptions, the atoms of the target are arbi-
trarily ordered, a1, ., aM, and the recursive procedure (for
pseudocode, see ESI, Section S3†) is applied to generate a set of
desired isotopomers. To explain this procedure, let us consider
methanol as the target, a hypothetical available_iso ¼ [2H, 17O,
and 18O], and S ¼ 2. Let us dene labellings (j, k, S) as a set of
labellings of atoms aj, ., ak, giving a mass shi S. Then label-
lings (1, M, S) refer to the set of isotopomers we ultimately seekThis journal is © The Royal Society of Chemistry 2019(pending de-duplication of possible identical structures). For
the specic CH3OH target, let us order atoms a1, a2, a3, a4, a5, a6
¼ C, H1, H2, H3, O, H4 (upper-right indices are used to distin-
guish between hydrogen atoms), and commence from a1¼ C. As
available_iso does not contain any isotopic label for carbon, no
isotopic labelling can be applied to a1 and the set of appropriate
labellings can be therefore written recursively as equation (*)
labellings (1, M, S) ¼ {a1 ¼ 12C}  labellings (2, M, S), where 
stands for set multiplication. Moving to the second atom, a2 ¼
H1, it can be labelled deuterium (mass shi of +1) or le
unlabelled (no mass shi), and so we have (**) labellings (2, M,
S) ¼ {a2 ¼ 2H}  labellings (3, M, S  1)W{a2 ¼ 1H}  labellings
(3,M, S). By combining (*) and (**) we obtain labellings (1,M, S)
¼ {a1 ¼ 12C, a2 ¼ 2H}  labellings (3, M, S  1)W{a1 ¼ 12C, a2 ¼
1H}  labellings (3, M, S). The procedure is continued until the
last atom is reached (a6 for methanol) and all acceptable
labelling options are returned. For the methanol example we
considered, aer de-duplicating the same chemical structures
(i.e., removing molecules with the same canonical SMILES
representation), there are ve viable isotopomers, written here
in the SMILES notation that is used as an input to the retro-
synthetic search: [2H]CO[2H], C[18O], [2H][17O]C, [2H]C[17O],
[2H]C([2H])O.
Results and discussion
Chemical examples implemented in Chematica
The algorithms detailed in the preceding sections can be
implemented in various retrosynthetic platforms. Since we have
been actively involved in the development of and continue to
have access to Sigma-Aldrich’s Chematica, we illustrate how the
algorithms function in this particular environment.
As described in several of our publications on Chematica,17–21
this platform is based on the knowledge-base of over 75 000
expert-coded reaction rules reecting reaction mechanisms,
delineating carefully substituent scope as well as contextual
information about potential cross-reactivity conicts, protec-
tion requirements, selectivity issues, etc. (for examples, see ref.
17 and ESI of ref. 18 and 20). The rules have variants applicable
to synthesis of isotopically labelled compounds and are
augmented by various modules based on quantum-mechanical,
molecular-mechanical, machine-learning, or heuristic
measures of reactions' electronic and steric requirements.17,20,39
The bipartite synthetic graphs created by the application of
reaction rules are navigated with the help of scoring functions
assigning costs for each reaction operation performed (with
additional costs added to reactions requiring, e.g., protection
chemistries) and evaluating structural complexity of the sets of
synthon molecules produced in each step. The searches are
supplemented by routine checking of the multi-step logic of
syntheses – for instance, they prevent dragging highly reactive
groups along multiple steps, penalize contraction of certain
macrocycles, or allow overcoming local complexity maxima by
the use of the so-called tactical combinations. Once feasible
routes are found, they are scored according to realistic pricing
models21 based on the prices of commercially available starting
materials (>200 000 chemicals from Sigma-Aldrich includingChem. Sci., 2019, 10, 9219–9232 | 9223
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View Article Online1100 isotopically labelled ones) and approximate yet realistic
reaction yields.40,41 The chemical correctness of all these algo-
rithms has been corroborated by successful experimental
execution of a number of Chematica-planned, multistep
syntheses.18,19
The multi-target design interfaced with Chematica entails
specication of the target library, either by drawing all its
members in a structure editor or by dening a Markush struc-
ture written in the SMILES notation42 (Fig. 1c and d) or, for
isotopomers, by specifying the desired mass increase and the
isotopes that can be used. The results of the searches are pre-
sented to the user as a “global” graph encompassing, depending
on the search modality, syntheses of all or some, most
synthetically accessible targets. Each substance and reaction
node can be expanded to provide, respectively, additional
structural and synthetic details (see ESI, Section S5–S11†).Synthesis of all members of a Prozac-derived library
Let us begin with a simple example in which we seek syntheses
of all members of a small library around a selective serotonin
reuptake inhibitor, uoxetine (Prozac). The library admits four
diﬀerent substituents (p-F, p-Cl, p-CF3 and H) in the aryl ether
part of uoxetine and three diﬀerent moieties on the N-termi-
nated side chain (NHMe, NHEt and NHAc), corresponding to 12
compounds in total (Fig. 4a). Within ca. 5 min, Chematica
produced tens of global plans for the syntheses of all the library
members, with the top-scoring solution graph shown in Fig. 4b
and with chemical details elaborated in Fig. 4c (for raw
Chematica screenshots and suggested reaction conditions, see
Fig. S4†). The common root of all syntheses is the Friedel–Cras
acylation of benzene with acyl chloride derived from N-acetyl b-
aminopropionic acid. Subsequent enantioselective reduction
(controlled, e.g., by the Corey–Bakshi–Shibata catalyst43 or
Noyori's catalyst44) yields an enantioenriched secondary alcohol
which is reacted with appropriate phenols under Mitsunobu
conditions to give the desired N-acyl series A2–D2. The N-ethyl
substituted compounds A3–D3 can then be obtained in one step
via reduction of the acetyl moieties while the preparation of N-
methyl series A1–D1 requires hydrolysis of acetamide and
subsequent reductive amination with formaldehyde. Impor-
tantly, the entire scheme to prepare 12 diﬀerent compounds
requires only 18 individual reactions and takes advantages of
several common intermediates including interconversions of
some library members. We note that the proposed strategy
comprising enantioselective reduction of appropriate b-ami-
noacetophenone44–46 and Mitsunobu displacement with
phenol47,48 has already been used in several syntheses of struc-
turally related compounds including our synthesis of hydrox-
yduloxetine.18 We also emphasize that this “global” synthetic
plan is diﬀerent from the plans that Chematica produces for
each target separately – for instance, if the program's task is to
make des-triuoromethyl congener of uoxetine A1 (Fig. 5a–c
and S5†), it uses the enantioselective allylation of aldehyde and
ozonolysis mimicking Bracher's approach.49 The same strategy
is returned as the top solution if A3 (Fig. 5d and S6†) or D3
(Fig. 5e and S7†) is an individual target. We note that none of9224 | Chem. Sci., 2019, 10, 9219–9232the top-three approaches found by Chematica in single-target-
oriented searches for A1 (Fig. 5a–c and S5†) – relying on either
the Friedel–Cras acylation with carbamate protected b-ami-
nopropionic acid50 or enantioselective arylation of aldehydes51,52
– are desirable for the design of the entire library. This is so
because these syntheses cannot take advantage of late common
intermediates and require several additional reactions (e.g., for
the optimal individual solution to A1, adaptation to the all-
library synthesis would entail a total of 21 distinct reactions
(allylation, four displacements with phenols, four hydro-
borations, and twelve aminations). The soware is not using the
elegant three-component Mannich reaction (the one we
employed previously in ref. 18 for the construction of a struc-
turally similar scaﬀold of hydroxyduloxetine) because it cannot
be adapted for the synthesis of the current library – in partic-
ular, the Mannich reaction cannot be performed with acet-
amide instead of methylamine to yield the N-Ac series A2–D2.
We also note that this design example illustrates well typical
gains in terms of computational eﬃciency: the search on
a common graph to identify the rst viable solution requires
exploration of ca. 10 times less nodes compared to the case
when the syntheses of the 12 targets are searched separately (cf.
Table S1 in the ESI, Section S4†).
Synthesis of all members of the Almorexant-derived library
In a more chemically advanced example, we consider synthesis
of a library centered around Almorexant, a drug developed by
Actelion and GSK for the treatment of insomnia. The library
accepts four diﬀerent substituents (p-F, p-CF3, p-tBu and 3,4-
diOMe) in the phenylethyl part of Almorexant and two diﬀerent
N-substituents, corresponding to eight compounds in total
(inset in Fig. 6a). Within ca. 30min, Chematica identied global
synthetic plans with the top-scoring solution graph shown in
Fig. 6a and with chemical details elaborated in Fig. 6b (for raw
Chematica screenshots and suggested reaction conditions, see
the ESI, Fig. S8†). The synthesis of each library member
commences with the oxidation of appropriate terminal alkenes
to aldehydes. The key formation of chiral tetrahydroisoquino-
lines leading to four common intermediates (marked with
arrows in Fig. 6a and colored orange in Fig. 6b) is accomplished
via enantioselective Pictet–Spengler cyclisation controlled
either by a chiral auxiliary or chiral catalyst.54 Subsequent
alkylation with the commercially available secondary benzyl
bromide A or condensation with a derivative of mandelic acid B
yields the target molecules.
Synthesis of all members of a library of RANKL/RANK
inhibitors
Our last example of all-library design is important in that the
computer's autonomous design can be directly compared with
and validated against recent experimental work. Specically, we
challenged Chematica with the synthesis of a subset of a library
of RANKL/RANK inhibitors reported very recently by Yang and
co-workers.53 In this task the library, represented as the Mar-
kush structure in the inset of Fig. 7a (for full representation see
Fig. S9†), consisted of 20 derivatives of tryptophan withThis journal is © The Royal Society of Chemistry 2019
Fig. 4 Retrosynthetic search to synthesize all members of a library around ﬂuoxetine scaﬀold. (a) All members of the library. (b) The corre-
sponding Markush structure and the screenshot from Chematica showing the top-scoring solution to synthesize all of the speciﬁed targets. In
this graph, yellow circular node¼Markush structure; small, blue, diamond-shaped node¼ “dummy” reaction connecting all speciﬁc targets A1–
D3 to the root node; leftmost column of 12 circular nodes¼ speciﬁc A1–D3 targets, mostly unknown in the NOC repository35,36 (violet nodes) but
one known (D1, number 9 inside of the node means that nine syntheses of this compound have been reported in the literature); red nodes ¼
terminal, commercially available chemicals, numbers inside the nodes indicate prices per gram (from Sigma-Aldrich catalog). Note that several
substances are common intermediates in multiple pathways and all 12 compounds are made in 18 steps in total. Details of synthetic plans are
provided in panel (c). For raw Chematica output and further details, see Fig. S4.†
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View Article Onlinediﬀerent N-alkyl (Z ¼ CH2) or N-acyl fragments (Z ¼ C]O),
diﬀerent linker lengths (n ¼ 1–4) and substituents (R ¼ alkyl,
aryl, heteroaryl). The search was allowed to run for ca. 15 min
and returned as the top-scoring solution the synthetic plan
shown as a graph in Fig. 7a and further detailed in Fig. S10 and
S11.† Within this plan, the synthesis of each library member isThis journal is © The Royal Society of Chemistry 2019accomplished in a short (three-four steps) sequence,
commencing with the coupling between commercially available
N-Boc tryptophan and 2,6-dimethylaniline. Subsequent removal
of the protecting group gives a common intermediate (in
Fig. 7a, the rightmost node marked with an orange arrow).
Finally, coupling with appropriate carboxylic acids or primaryChem. Sci., 2019, 10, 9219–9232 | 9225
Fig. 5 Top-scoring solutions proposed by Chematica for the synthesis
of individual members of the ﬂuoxetine library: (a–c) target A1, (d)
target A3, and (e) target D3. Node coloring scheme is as in Fig. 4. For
raw Chematica output and synthetic details, see Fig. S5–S7.†
Fig. 6 Retrosynthetic search to synthesize all members of a library of
analogues of Almorexant. (a) Markush structure representing proposed
library (white inset, top-left), lists of substituents (bottom left) and
graph representation of the top-scoring solution. Chemical details are
shown in panel (b). Note that several substances (marked with arrows
and colored orange in panel (b)) are common intermediates inmultiple
pathways while the entire library is prepared from single phenyleth-
ylamine. For raw Chematica output and further details, see Fig. S8.†
Node coloring scheme is as in Fig. 4.
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View Article Onlinemesylates leads to N-acyl or N-alkyl target molecules, respec-
tively. Remarkably, this approach mirrors closely the strategy
used in Yang and co-workers' experiments.53Synthesis of the most accessible derivatives of a k-opioid
agonist
To illustrate the synthetic design of not all but only the most
accessible members of a given library, we considered derivatives
of a selective k-opioid agonist55 ICI-199441 (Fig. 8). The ICI-
199441 scaﬀold was decorated with three substituents in the
N-terminated side chain, four substituents in the benzylamine
part, and four combinations of halogens in the arylacetic acid
part, overall corresponding to 48 distinct members of the library
(Fig. 8a). The top ve of the several hundreds of viable pathways9226 | Chem. Sci., 2019, 10, 9219–9232(identied within 10 min) are shown in Fig. 8b–f and further
detailed in Fig. S12.† In each of these plans, the molecule of
interest (one node before the yellow node; compared with the
scheme in Fig. 3b) can be obtained in three steps using alkyl-
ation of an appropriate secondary amine with a commercially
available protected phenylglycinol, removal of the protecting
group, and a sulfur catalyzed Willgerodt–Kindler (WK) reac-
tion56 yielding the desired arylacetic acid amides from aceto-
phenones. The application of this last methodology – whileThis journal is © The Royal Society of Chemistry 2019
Fig. 7 Retrosynthetic search to synthesize a subset of a recently re-
ported library of tryptophan derivatives acting as RANKL/RANK inhib-
itors.53 (a) Markush structure representing proposed library (white
inset) and graph representation of the top-scoring solution. All
members of the library are prepared from one common intermediate
marked with arrow in (a) and colored orange in panel (b) which details
synthesis of one of the library members. For Chematica's raw output
for the entire library, see Fig. S10 and S11.†
Fig. 8 Retrosynthetic analysis of ICI199441 derivatives. (a) Left portion sh
library of 48 members; right portion shows the structure of the original I
from (a). Note that in plan (d), the algorithm found a commercially availab
continued the search until it found less expensive substrates with prices
synthetic details, see Fig. S12.†
This journal is © The Royal Society of Chemistry 2019
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View Article Onlinechemically correct – might, at rst glance, appear counterintu-
itive given that such amides are usually55,57 formed in reactions
of acyl halides or carboxylic acids. These more conventional
plans were, indeed, present in the top 100 solutions identied
by the soware, but the algorithm correctly gave them lower
scores based on higher prices of substrates – namely, applica-
tion of the WK reaction allowed for the use of cheaper aceto-
phenone substrates rather than appropriate arylacetic acids
($1.91 vs. $3.23 per g of dichloroderivative and $3.21 vs. $5.81
per g of the 4-F-3-Cl derivative). Consequently, the diethylamino
congeners were found to be more accessible than morpholino-
or cyclopentylamino ones. We also note that none of the
compounds substituted in the benzylamine part appeared
among the most accessible targets as their synthesis requires
construction of appropriate chiral aminoalcohols.Syntheses of isotopically labelled targets
In our last set of examples, we used the algorithm to determine
which isotopically labelled compounds from a given library of
isotopomers are synthetically most readily accessible.
(i) Cinacalcet. Fig. 9 shows ve top-scoring syntheses of
Amgen's cinacalcet (Sensipar/Mimpara), whose mass we wish to
increase by S ¼1 by single labelling with either 13C or 2H (thereows the Markush structure and dictionary of substituents deﬁning the
CI199441 compound. (b–f) Five top-scoring synthetic plans for library
le advanced intermediate (red node with price per gram ¼ $58.60) but
per gram below the user-speciﬁed threshold of $50 per g. For further
Chem. Sci., 2019, 10, 9219–9232 | 9227
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View Article Onlineare 39 unique isotopomers). In the rst proposed synthesis
(Fig. 9a), the 13C isotopic label is located on the methyl group
and introduced from bromomethane. In the rst step, chiral-
auxiliary-directed addition58,59 of an organometallic reagent
derived from 13CH3Br yields the enantioenriched secondary
amine which is then alkylated with a commercially available
alcohol to give the molecule of interest. In the second plan
(Fig. 9b), the 2H isotope label is introduced from D2O during the
Shapiro reaction proposed as the rst step. Subsequent Rh-
mediated hydroaminomethylation gives the 2H-cinacalcet also
aer 2 steps. In the third plan (Fig. 9c), 13C labelled cinacalcet is
made in only one step, via three-component hydro-
aminomethylation utilizing commercially available styrene,
enantioenriched secondary amine, and 13C carbon monoxide.
We observe that such a carbonylative approach has been already
used by Amgen to prepare unlabeled cinacalcet.60 In the fourth
plan (Fig. 9d), the labelled 13C atom is located at the chiral
carbon and comes from the 13C acetic acid used in the initial
Friedel–Cras acylation of naphthalene.61 Subsequent reductive
amination guided by a chiral auxiliary62 or a chiral catalyst63,64
yields the secondary amine transformed into the target mole-
cule following steps from the rst plan. Finally, cinacalcet can
be labelled with 2H located at the methyl group with a deute-
rium atom introduced from 2H-methyl iodide participating in
direct enantioselective alkylation of naphthylacetic acid65
controlled by a chiral diamine (Fig. 9e). Subsequent trans-
formation of carboxylic acid into secondary amine via the
Schmidt reaction66 yields the amine which is subjected to the
reaction with alcohol to give the target molecule. We note that
the proposed approaches relying on the alkylation of chiral
naphthylamine are corroborated by published syntheses67–71 of
unlabeled cinacalcet.
(ii) AMG-319. The second example in this section describes
synthesis of M + 1 isotopomers of Amgen's AMG-319, theFig. 9 Syntheses of cinacalcet singly-labelled with either 13C (a, c and d)
top-scoring routes are shown. For further synthetic details, see Fig. S13.
9228 | Chem. Sci., 2019, 10, 9219–9232inhibitor targeted for autoimmune diseases72 and head and
neck squamous-cell carcinomas.73 The proposed solution
(Fig. 10a) commences with the Suzuki coupling of 2-pyridyl
boronic acid and 2-chloropyridine. Subsequent conversion to
an imine and stereoselective addition58 of the organometallic
reagent derived from 13CH3Br yields the enantioenriched
benzylic amine which is coupled with hypoxanthine in the last
step. We note that this computer-designed synthetic plan
resembles Amgen's original route72 to unlabelled AMG-319.
(iii) Lasmiditan. In the third example, the algorithm is used
to design syntheses of M + 1 lasmiditan developed by Eli Lilly for
the treatment of acute migraine. Aer specifying the admissible
isotope label (here, 13C), desired mass shi S ¼ 1 (correspond-
ing to 15 isotopomers) and excluding 13C N-methylated iso-
topomer prone to hepatic cleavage observed previously for N-
methyl piperazines,23,74–76 the search was run for ca. 10 min and
returned hundreds of viable synthetic plans from which the top-
scoring one is shown in Fig. 10b. In the rst step, the appro-
priate 2-chloropyridine is constructed in one step via addition
of a Grignard reagent, obtained from the N-methyl-4-
bromopiperidine, to 2-cyano-6-chloropyridine. The isotope
label is introduced from 13CO2 used for the formation of
carboxylic acid from the organolithium reagent derived from
triuorobenzene.77 The following steps resemble the original
route to lasmiditan.78 Subsequent amination of 2-chloropyr-
idine and reaction with labelled benzoic acid yield the molecule
of interest in a four-step sequence.
(iv) Roluperidone. In the fourth example, Chematica designs
syntheses of M + 1, 13C labelled congener of roluperidone
developed by Minerva Neurosciences for the treatment of
schizophrenia.79 The top-scoring plan returned aer ca. 10 min
is shown in Fig. 10c. The proposed short sequence commences
with the N-alkylation of hydroxymethylpiperidine with the
appropriate chloroacetophenone. Subsequent alkylation of 2-or 2H (b and e). Several viable routes were identiﬁed within 10 min; ﬁve
†
This journal is © The Royal Society of Chemistry 2019
Fig. 10 Retrosynthetic design of isotopically labeled drugmolecules. In all cases, 13C labeling was allowed and the desiredmass shift was S¼ +1.
Top-scoring and in all cases chemically viable solutions obtained for (a) a library of 21 isotopomers of AMG-319; (b) a library of 14 isotopomers of
lasmiditan; (c) a library of 18 isotopomers of roluperidone; (d) a library of 13 isotopomers of pitolisant; (e) a library of 13 isotopomers of almo-
triptan. For further details of the pathways, see Fig. S14–S18.†
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View Article Onlinebromobenzylamine with the remaining primary alcohol yields
the substrate amenable to intramolecular carbonylative ami-
dation.80 The 13C label is introduced in this step and sourced
from 13CO, completing the synthesis in just three steps. The
proposed plan resembles Mitsubishi's synthesis of roluper-
idone utilizing proposed hydroxymethylpiperidine and phe-
nacyl bromide as building blocks and participating in SN2
alkylations of benzolactams and secondary amines;81 moreover,
the proposed carbonylative N-alkylation has been used in
Astellas' synthesis of N-benzyl benzolactams.82
(v) Pitolisant. The h example illustrates eﬃcient prepa-
ration of M + 1, 13C labelled pitolisant (Wakix), developed by
Bioprojet for the treatment of hypersomnia.83,84 The search
performed for ca. 10 min returned multiple solutions from
which the top-scoring one is shown in Fig. 10d. The entire
sequence requires only two steps and sources the 13C atom from
labelled bromoacetic acid used in the rst step to N-alkylate85
hydroxypropylpiperidine. The obtained alkoxyacid is then used
in MacMillan's decarboxylative coupling86 with commercially
available phenethyl bromide to give the target molecule. The
proposed plan resembles Bioprojet's one-step solution87 which
also used hydroxypropylpiperidine alkylated with the appro-
priate alkyl bromide.
(vi) Almotriptan. In the sixth and last example, we aim to
design routes to labelled almotriptan developed by Almirall for
the treatment of severe migraine headache. Aer specifying theThis journal is © The Royal Society of Chemistry 2019plausible isotopes (13C) and mass shi S¼ 1 and precluding the
N-Me labelled isotopomers prone to hepatic cleavage,23,88–90 the
search was run for 10 min and returned as its top-scoring
solution pathway shown in Fig. 10e. Somewhat counterintui-
tively, the isotope label in the most accessible isotopomer is
located inside the indole ring and comes from 13CO. The
proposed synthetic plan starts from the commercially available
aniline transformed into an appropriate hydrazine. Subsequent
Rh-catalyzed tandem hydroformylation/indolisation91 builds
the central ring system, introduces the isotope label and
attaches the dimethylaminoethyl side chain and yields the
target molecule in a two-step sequence. Similar, elegant car-
bonylative tandem indolisation was already used in Sheldon's
one-pot synthesis of unlabeled melatonin.92
Conclusions
In summary, we described how the search routines over large
graphs of retrosynthetic scenarios can be adapted to nd all or
some members of target compound libraries. For the nd-all
variant, the “global” synthetic plans can benet from the use
of common intermediates and can be signicantly diﬀerent
from optimal solutions found for each target separately – that is
to say, the global solutions might be counterintuitive for human
planners accustomed to optimizing specic synthetic routes
rather than interconnected networks of such routes. AnotherChem. Sci., 2019, 10, 9219–9232 | 9229
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View Article Onlineapplication we consider quite useful is the synthesis of iso-
topomers. Here, the catalogs of isotopically labelled starting
materials are signicantly less populous than those of unla-
belled building blocks, and many blocks that are considered
“basic” are not available in labelled forms. Consequently,
synthetic design is oen non-intuitive and it is not straight-
forward to predict which of the potential isotopomers would be
the easiest one to make – a question our algorithms can handle
rapidly and eﬃciently. Overall, this work extends the scope of
computer-assisted synthetic planning to new problems that are
common and important in pharmaceutical and agrochemical
industries.
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